Application of plasma alternative to serum for measuring leucine-rich α2-glycoprotein as a biomarker of inflammatory bowel disease.

Tadashi IchimiyaTomoe KazamaKeisuike IshigamiYoshihiro YokoyamaYuki HayashiSatoshi TakahashiTakao ItoiHiroshi Nakase

Published in: PloS one (2023)

The present study showed that plasma LRG levels correlate well with serum LRG levels. Therefore, plasma LRG can be clinically applied as a biomarker for assessing endoscopic disease activity in patients with IBD.

Keyphrases

disease activity
systemic lupus erythematosus
rheumatoid arthritis
ankylosing spondylitis
rheumatoid arthritis patients
juvenile idiopathic arthritis
ultrasound guided
ulcerative colitis